Peripherally restricted μ-opioid receptor antagonists: a review

Wood, 2004, Function of opioids in the enteric nervous system, Neurogastroenterol Motil, 16, 17, 10.1111/j.1743-3150.2004.00554.x Holzer, 2004, Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans, Neurosci Lett, 361, 192, 10.1016/j.neulet.2003.12.004 Levy, 1996, Pharmacological treatment of cancer pain, N Engl J Med, 335, 1124, 10.1056/NEJM199610103351507 2006, Laxatives for the management of constipation in palliative care patients, Cochrane Database Syst Rev, 4 Bell, 2007, Opioid-induced constipation compromises pain management and impacts patient quality of life, AAPM Abbound, 1990, Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia, Anesth Analg, 71, 367 Syke, 1991, Oral naloxone in opioid-associated constipation, Lancet, 337, 1475, 10.1016/0140-6736(91)93162-3 Culpepper-Morgan, 1992, Treatment of opioid-induced constipation with oral naloxone: a pilot study, Clin Pharmacol Ther, 52, 90, 10.1038/clpt.1992.106 Latasch, 1997, Treatment of morphine-induced constipation with oral naloxone, Anaesthesist, 46, 191, 10.1007/s001010050390 Meissner, 2000, Oral naloxone reverses opioid-associated constipation, Pain, 84, 105, 10.1016/S0304-3959(99)00185-2 Yuan, 1997, The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time, Clin Pharmacol Ther, 61, 467, 10.1016/S0009-9236(97)90197-1 Yuan, 2000, Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time, Clin Pharmacol Ther, 67, 398, 10.1067/mcp.2000.105037 Liu, 2001, ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia, Clin Pharmacol Ther, 69, 66, 10.1067/mcp.2001.112680 Yuan, 2000, Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial, J Am Med Assoc, 283, 367, 10.1001/jama.283.3.367 Yuan, 2002, Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial, J Pharmacol Exp Ther, 300, 118, 10.1124/jpet.300.1.118 Paulson, 2005, Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction: a 21-day treatment-randomized clinical trial, J Pain, 3, 184, 10.1016/j.jpain.2004.12.001 Gonenne, 2005, Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study, Clin Gastroenterol Hepatol, 8, 784, 10.1016/S1542-3565(05)00434-9 Luckey, 2003, Mechanisms and treatment of postoperative ileus, Arch Surg, 138, 206, 10.1001/archsurg.138.2.206 Delaney, 2006, Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials, Am J Surg, 91, 315, 10.1016/j.amjsurg.2005.10.026 Livingston EH: personal communication, Sept 29, 2006 Kalff, 2003, Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy, Ann Surg, 237, 301, 10.1097/01.SLA.0000055742.79045.7E Bult, 1990, Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter, Nature, 345, 346, 10.1038/345346a0 DeJonge, 2003, Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice, Gastroenterology, 125, 1137 Cali, 2000, Effect of morphine and incision length on bowel function after colectomy, Dis Colon Rectum, 43, 163, 10.1007/BF02236975 Shahbazian, 2002, Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine, Br J Pharmacol, 135, 741, 10.1038/sj.bjp.0704527 Wolff, 2004, Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus, Ann Surg, 240, 728, 10.1097/01.sla.0000141158.27977.66 Delaney, 2005, Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery, Dis Colon rectum, 48, 1114, 10.1007/s10350-005-0035-7 Viscusi, 2006, Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery, Surg Endosc, 20, 64, 10.1007/s00464-005-0104-y Leslie, 2006, Alvimopan oral dosing 30-90 minutes before and BID after bowel resection accelerated GI recovery, Anesthesiology, 105, A122 Gan, 2006, Methylnaltrexone in post-operative bowel dysfunction: results of a double-blind, randomized, placebo-controlled trial in segmental colectomy patients, IARS Abstract Yuan, 1998, Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine, Drug Alcohol Depend, 52, 161, 10.1016/S0376-8716(98)00087-8 Foss, 1993, Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs, J Clin Pharmacol, 33, 747, 10.1002/j.1552-4604.1993.tb05618.x Foss, 1998, Prevention of apomorphine-induced. or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine, Cancer Chemother Pharmacol, 33, 747 Moerman, 1995, Evaluation of methylnaltrexone for the reduction of postoperative vomiting and nausea incidencies, Act Anaesthesiol Belg, 46, 127 Vallejo, 2004, Opioid therapy and immunosuppression: a review, Am J Ther, 11, 354, 10.1097/01.mjt.0000132250.95650.85 Ho, 2003, Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes, J Pharmacol Exp Ther, 307, 1158, 10.1124/jpet.103.056697 Gupta, 2002, Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth, Cancer Res, 62, 4491 Poonawala, 2005, Opioids heal ischemic wounds in the rat, Wound Repair Regen, 13, 165, 10.1111/j.1067-1927.2005.130207.x Moss, 2006, Morphine induced angiogenesis is blocked by methylnaltrexone, Anesthesiology, 105, A1573 Singleton, 2006, Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation, Microvasc Res, 72, 3, 10.1016/j.mvr.2006.04.004